https://www.selleckchem.com/products/ew-7197.html
The interaction of iron and iron-containing proteins with dietary and xenobiotic molecules, including drugs, may affect iron metabolic and disease processes. Deferiprone, deferoxamine, deferasirox and other chelating drugs can offer therapeutic solutions for most diseases associated with iron metabolism including iron overload and deficiency, neurodegeneration and cancer, the detoxification of xenobiotic metals and most diseases associated with free radical pathology.Liver cancer is the sixth most common cancer in terms of incidence and
Gefällt mir
Kommentar
Teilen
